000 01350 a2200373 4500
005 20250514073527.0
264 0 _c20031118
008 200311s 0 0 eng d
022 _a0169-5002
024 7 _a10.1016/s0169-5002(03)00156-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKosmidis, Paris A
245 0 0 _aAdvanced NSCLC: new cytostatic agents.
_h[electronic resource]
260 _bLung cancer (Amsterdam, Netherlands)
_cAug 2003
300 _aS123-32 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aCamptothecin
_xanalogs & derivatives
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xdrug therapy
650 0 4 _aClinical Trials as Topic
650 0 4 _aEpothilones
_xpharmacology
650 0 4 _aGlutamates
650 0 4 _aGuanine
_xanalogs & derivatives
650 0 4 _aHumans
650 0 4 _aIrinotecan
650 0 4 _aLung Neoplasms
_xdrug therapy
650 0 4 _aOrganoplatinum Compounds
_xpharmacology
650 0 4 _aOxaliplatin
650 0 4 _aPemetrexed
650 0 4 _aThymidylate Synthase
_xantagonists & inhibitors
700 1 _aManegold, Christian
773 0 _tLung cancer (Amsterdam, Netherlands)
_gvol. 41 Suppl 1
_gp. S123-32
856 4 0 _uhttps://doi.org/10.1016/s0169-5002(03)00156-9
_zAvailable from publisher's website
999 _c12644901
_d12644901